Home > Journals > RFP Gastroenterology International

RFP Gastroenterology International

Submit your article Read this Journals View all journals
Full Text (PDF)
Review Article

Cytomegalovirus in Inflammatory Bowel Disease - Clinical Relevance.

Viswanath Reddy Donapati, , 1Viswanath Reddy Donapati , 2G. R. Srinivas Rao , 3Y , Rami Reddy

Author Information

Licence:



RFP Gastroenterology International 4(1-2):p 5-19, January – December 2019. | DOI:

How Cite This Article:

 

Viswanath Reddy Donapati, G. R. Srinivas Rao, Y Rami Reddy. Cytomegalovirus in Inflammatory Bowel Disease - Clinical
Relevance. Gastroenterology International. 2018;3(1-2):5-11.
 

Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background: Cytomegalovirus is a common and self-limiting infection in general population, but in immunocompromised states it has been implicated in severe complications like pneumonia and colitis. It could also be an innocent bystander(coloniser) in colon. In Inflammatory bowel disease there has been an association with severe colitis and flares of disease,with a reported prevalence of 4.5–16.6%, and as high as 25% in patientsrequiring colectomy for severe colitis. The role of CMV in the deterioration of the IBD disease is still debatable. There is also no global consensus in defining this entity. The clinical relevance of the presence of CMV in IBD patients is our question-whether it is a bystander or clinically significant. Aim: To analyse the clinical relevance of Cytomegalovirus in patients with inflammatory bowel disease, including epidemiology, clinical features, diagnosis and management options. Methods: Literature search was made using Pubmed, EMBASE and the Cochrane resources with the search words: CMV in Inflammatory Bowel disease, cytomegalovirus colitis, CMV treatment. Results: Cytomegalovirus infection is common in patients with Inflammatory Bowel Disease. CMV disease and CMV reactivation is common in patients with severe colitis, with a prevalence of 4.5–16.6%, and upto 25% in patients with severe colitis requiring colectomy. The clinical outcome of patients with reactivation is poorer compared to those without reactivation. However, 71-86% of patients who underwent treatment with antivirals showed disease remission. Conclusions: From the literature review, we can infer that, testing for CMV should be considered in patients with flare of disease having moderate to severe activity, by doing biopsies for microscopic evidence of CMV activity, Immunohistochemistry, tissue for Real time Polymerase Chain reaction. Ganciclovir treatment showed good results in these group of patients. Key Words: Cytomegalovirus infection, Cytomegalovrus Disease, Inflammatory Bowel Disease, Flare, Severe Colitis, Steroid Refractory Colitis, Clinical relevance.

References

No records found.


About this article

Cite this article

 

Viswanath Reddy Donapati, G. R. Srinivas Rao, Y Rami Reddy. Cytomegalovirus in Inflammatory Bowel Disease - Clinical
Relevance. Gastroenterology International. 2018;3(1-2):5-11.
 

Licence:



Received Accepted Published
N/A N/A N/A
DOI:

Keywords


Article Level Metrics

Last Updated

Monday 26 January 2026, 20:20:38 (IST)

571

Accesses

2
29
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received N/A
Accepted N/A
Published N/A

licence




Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share